Cyanotech (CYAN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting is scheduled for August 22, 2024, to elect four directors, approve a new director equity plan, ratify the external auditor, and address other business.
Shareholders of record as of June 28, 2024, are eligible to vote, with multiple voting methods available including mail, phone, and internet.
Proxy materials and the annual report are accessible online, with options for electronic or paper delivery.
Voting matters and shareholder proposals
Four director nominees are up for election to serve until the next annual meeting.
Shareholders will vote on the 2024 Independent Director Stock Option and Restricted Stock Grant Plan, reserving 800,000 shares for director equity awards.
Ratification of Grant Thornton LLP as the independent registered public accounting firm for fiscal year ending March 31, 2025, is on the agenda.
Procedures for shareholder proposals and nominations for the 2025 meeting are detailed, with specific deadlines and requirements.
Board of directors and corporate governance
The board will be reduced from five to four members, all current directors, with backgrounds in management, finance, and industry expertise.
Three of four nominees are independent under OTCQB rules; the CEO is not considered independent.
The board separates the roles of CEO and chairman for governance efficiency.
Board committees include Audit, Compensation, and Nominating & Corporate Governance, each with independent directors and formal charters.
Directors attended 100% of board and committee meetings in fiscal 2024.
Latest events from Cyanotech
- Flat sales, lower margins, and new product launches amid cost pressures and secured financing.CYAN
Q4 20243 Feb 2026 - Net sales up 15% to $5.9M, but gross margin and liquidity pressures persist.CYAN
Q1 20252 Feb 2026 - Annual meeting to elect directors, approve equity plan, and ratify auditor, with governance focus.CYAN
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and triennial say-on-pay vote headline the agenda.CYAN
Proxy Filing2 Dec 2025 - Gross margin rose to 30.5% and net loss narrowed despite flat Q1 FY2026 revenue.CYAN
Q1 202623 Nov 2025 - Q2 sales up 19.3%, gross margin at 34.3%, operating income positive, but liquidity risks remain.CYAN
Q2 202618 Nov 2025 - Revenue up 5% and losses narrowed, but going concern risk remains due to liquidity and debt issues.CYAN
Q4 202520 Jun 2025 - Q2 FY2025 saw lower sales, margin compression, and ongoing liquidity challenges.CYAN
Q2 202513 Jun 2025 - Q3 sales rose 10.6% YoY, but ongoing losses and liquidity risks raise going concern doubts.CYAN
Q3 20255 Jun 2025